Literature DB >> 30527564

Severe Hypoglycemia Due to Cryptic Insulin Use in a Bodybuilder.

Matthieu Heidet1, Abdel Abdel Wahab2, Vahid Ebadi3, Yann Cogne4, Charlotte Chollet-Xemard2, Mehdi Khellaf5.   

Abstract

BACKGROUND: Bodybuilding is a demanding sport, which requires high-volume, high-resistance weight training and augmented nutritional intake, toward an increase of overall body muscle mass accompanied by an overall decrease of body fat percentage and mass. Among bodybuilders, the use of various legal and illegal supplements is common. These supplements may be naturally occurring or man-made. CASE REPORT: We discuss the case of a 30-year-old male bodybuilder presenting with coma due to severe hypoglycemia from unknown cause, necessitating iterative glucose infusions, which was subsequently found to be related to cryptic insulin injections. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: In strength athletes, especially amateurs, the recourse to performance-enhancement drugs (e.g., insulin) is frequent. Beyond the specificity of care required for surreptitious insulin intoxication, emergency physicians should be alert to the possibility that exogenous insulin has been injected for use as an ergogenic aid by bodybuilders and others seeking to increase their body muscle mass when they encounter a patient with a decreased level of consciousness and treatment-refractory hypoglycemia. Moreover, in case of suspicion of such intoxication, the use of other illegal supplements should be screened, due to potentially associated risks of complication.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bodybuilding; drug abuse; emergency medicine; insulin intoxication

Mesh:

Substances:

Year:  2018        PMID: 30527564     DOI: 10.1016/j.jemermed.2018.10.030

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  1 in total

Review 1.  Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review.

Authors:  Alex K Bonnecaze; Thomas O'Connor; Cynthia A Burns
Journal:  J Gen Intern Med       Date:  2021-05-04       Impact factor: 6.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.